Tesamorelin
A stabilized analogue of GHRH studied for its effects on GH secretion and body composition.
Research Use Only. This product is intended for laboratory research purposes only and is not for human consumption. Not for sale to minors.
Product Description
Tesamorelin is a stabilized analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid group added to improve stability. Research has investigated its effects on GH secretion, IGF-1 levels, and body composition, particularly visceral adipose tissue.
Research Information
Research on Tesamorelin has demonstrated its ability to significantly reduce visceral adipose tissue in various study populations. Studies have investigated its effects on GH-IGF-1 axis, lipid metabolism, and cognitive function. Research has also explored its effects on cardiovascular risk markers.
Dosage Guidance
Research protocols use subcutaneous administration. Standard vials contain 1mg or 2mg lyophilized powder. All dosing information is for research reference only.